Gibraltar Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Gibraltar Capital Management's GILD Position: Q1 2023 in Review
Gibraltar Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 8,725 shares — an estimated $749K sold.
Gibraltar Capital Management first reported a position in GILD in Q1 2015 and held it in 12 quarters. The position peaked at $4.77M in Q1 2016. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.
- Gibraltar Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
- Gibraltar Capital Management sold 8,725 Gilead Sciences shares in Q1 2023, an estimated $749K.
- Gibraltar Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 12 quarters.
- Gibraltar Capital Management's Gilead Sciences position peaked at $4.77M in Q1 2016.
- 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.
Based on Gibraltar Capital Management's 13F filing for Q1 2023, filed 8 May 2023.